Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)

Dr. Rodolfo F. Nunez

Radiology | Nuclear Medicine
Pratt Anesthesiology Associates
Pratt Radiology Associates Inc
800 Washigton St, 
Boston, MA 
Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Pratt Anesthesiology Associates
Pratt Radiology Associates Inc
800 Washigton St, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rodolfo Nunez is a Radiologist and a Nuclear Medicine provider in Boston, Massachusetts. Dr. Nunez is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). His top areas of expertise are Neuroendocrine Tumor, Lymphofollicular Hyperplasia, Lung Nodules, and Primary Mediastinal B-Cell Lymphoma (PMBCL).

His clinical research consists of co-authoring 10 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiology
Nuclear Medicine
Licenses
Diagnostic Radiology in TX
Hospital Affiliations
Tufts Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

PRATT RADIOLOGY ASSOCIATES INC
800 Washigton St, Boston, MA 02111

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

PSMA-directed Targeted Alpha Therapy With FPI-2265 (225Ac-PSMA-I&T) for the Treatment of Metastatic Castration-resISTant Prostate Cancer (TATCIST). A Phase II Clinical Trial.
PSMA-directed Targeted Alpha Therapy With FPI-2265 (225Ac-PSMA-I&T) for the Treatment of Metastatic Castration-resISTant Prostate Cancer (TATCIST). A Phase II Clinical Trial.
Enrollment Status: Active_not_recruiting
Publish Date: October 08, 2025
Intervention Type: Drug
Study Drug: Ac225-PSMA I&T
Study Phase: Phase 2
A Phase 1, Non-Randomized, Open-Label, Dose Escalation, Single-Center Study to Determine the Safety, Bio-distribution, and Preliminary Effectiveness of AlphaMedix™ in Adult Subjects With SSRT(+) NETs.
A Phase 1, Non-Randomized, Open-Label, Dose Escalation, Single-Center Study to Determine the Safety, Bio-distribution, and Preliminary Effectiveness of AlphaMedix™ in Adult Subjects With SSRT(+) NETs.
Enrollment Status: Terminated
Publish Date: June 10, 2025
Intervention Type: Drug
Study Drug: AlphaMedix
Study Phase: Phase 1
A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE in Subjects With Somatostatin Receptor Expressing Neuroendocrine Tumors
A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE in Subjects With Somatostatin Receptor Expressing Neuroendocrine Tumors
Enrollment Status: Active_not_recruiting
Publish Date: June 04, 2025
Intervention Type: Drug
Study Drug: AlphaMedix
Study Phase: Phase 2
A Phase II, Non-Randomized, Open-Label, Single-center, Physician Sponsored Study to Determine the Safety and Effectiveness of Lu-177 DOTATOC in Adult Subjects With Somatostatin Receptor Expressing Pulmonary, Pheochromocytoma, paragangliomUnknown Primary, and Thymus Neuroendocrine Tumors (PUTNET) or Any Other Non-.GEP-NET.
A Phase II, Non-Randomized, Open-Label, Single-center, Physician Sponsored Study to Determine the Safety and Effectiveness of Lu-177 DOTATOC in Adult Subjects With Somatostatin Receptor Expressing Pulmonary, Pheochromocytoma, paragangliomUnknown Primary, and Thymus Neuroendocrine Tumors (PUTNET) or Any Other Non-.GEP-NET.
Enrollment Status: Withdrawn
Publish Date: March 10, 2023
Intervention Type: Drug
Study Drug: 177Lu-DOTATOC
Study Phase: Phase 2
View 3 Less Clinical Trials

10 Total Publications

Non-FDG PET/CT imaging of inflammatory arthritis.
Non-FDG PET/CT imaging of inflammatory arthritis.
Journal: Skeletal radiology
Published: January 07, 2025
Similar Doctors
Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Dr. Laura Drubach
Nuclear Medicine | Emergency Medicine
Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Dr. Laura Drubach
Nuclear Medicine | Emergency Medicine

Children's Hospital Radiology Foundation, Inc.

300 Longwood Ave, 
Boston, MA 
 (2.3 miles away)
Experience:
43+ years
Languages Spoken:
English
See accepted insurances

Laura Drubach is a Nuclear Medicine specialist and an Emergency Medicine provider in Boston, Massachusetts. Dr. Drubach has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). Her top areas of expertise are Classical Hodgkin Lymphoma, Primary Mediastinal B-Cell Lymphoma (PMBCL), Neurofibromatosis Type 1 (NF1), Neurofibromatosis, and Nerve Decompression.

Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Dr. Eric J. Sax
Radiology
Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Dr. Eric J. Sax
Radiology

Spectrum Healthcare Partners, PA

500 Atlantic Ave, Unit 14e, 
Boston, MA 
 (0.6 miles away)
844-947-4259
Languages Spoken:
English
See accepted insurances

Eric Sax is a Radiologist in Boston, Massachusetts. Dr. Sax is rated as an Advanced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). His top areas of expertise are Bronchogenic Cyst, Pleurisy, Pleural Effusion, and Emphysema.

Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Dr. Gustavo A. Mercier
Radiology | Nuclear Medicine
Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Dr. Gustavo A. Mercier
Radiology | Nuclear Medicine

Brigham And Womens Physicians Organization Inc

1 Winterberry Ln, 
Medway, MA 
 (24.3 miles away)
617-643-0003
Languages Spoken:
English
See accepted insurances

Gustavo Mercier is a Radiologist and a Nuclear Medicine provider in Medway, Massachusetts. Dr. Mercier is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). His top areas of expertise are Lung Nodules, Neuroendocrine Tumor, Primary Mediastinal B-Cell Lymphoma (PMBCL), and ALK-Positive Non-Small Cell Lung Cancer.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nunez's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile